Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Liu

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Oncotarget|December 17, 2021
Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Yasmine Baca, Joanne Xiu, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum AgentsSourat Darabi, David R Braxton, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancerStephen V Liu, Denice D Tsao-Wei, Shigang Xiong, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2026
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancerJennifer A Marks, Kieran Sweeney, Andrew Elliott, et al.
BMC Cancer|October 18, 2023
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencingMisako Nagasaka, Shannon S Zhang, Yasmine Baca, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family OncogenesAdriana Estrada-Bernal, Anh T Le, Andrea E Doak, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2024
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histologyJennifer A Marks, Nishant Gandhi, Balazs Halmos, et al.
The Oncologist|February 15, 2017
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary CancersBenjamin A Weinberg, Kyle Gowen, Thomas K Lee, et al.
Physical Biology|December 1, 2012
Genomic analysis and selected molecular pathways in rare cancersStephen V Liu, Elizabeth Lenkiewicz, Lisa Evers, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Oncotarget|December 17, 2021
Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Yasmine Baca, Joanne Xiu, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum AgentsSourat Darabi, David R Braxton, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancerStephen V Liu, Denice D Tsao-Wei, Shigang Xiong, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2026
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancerJennifer A Marks, Kieran Sweeney, Andrew Elliott, et al.
BMC Cancer|October 18, 2023
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencingMisako Nagasaka, Shannon S Zhang, Yasmine Baca, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family OncogenesAdriana Estrada-Bernal, Anh T Le, Andrea E Doak, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2024
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histologyJennifer A Marks, Nishant Gandhi, Balazs Halmos, et al.
The Oncologist|February 15, 2017
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary CancersBenjamin A Weinberg, Kyle Gowen, Thomas K Lee, et al.
Physical Biology|December 1, 2012
Genomic analysis and selected molecular pathways in rare cancersStephen V Liu, Elizabeth Lenkiewicz, Lisa Evers, et al.
Pageof 19